RCs and Their 95% CIs
| Parameter | Lower 95% RC | Upper 95% RC | 95% CI for lower RC | 95% CI for upper RC |
| SUVmax-A | −27% | 37% | −34% to −23% | 29% to 52% |
| SUVmax-M | −29% | 41% | −36% to −25% | 32% to 55% |
| SUVmax-P | −28% | 39% | −33% to −25% | 33% to 48% |
| SUVpeak-A | −28% | 39% | −35% to −23% | 31% to 54% |
| SUVpeak-M | −35% | 53% | −42% to −29% | 41% to 72% |
| SUVpeak-P | −32% | 47% | −37% to −28% | 39% to 59% |
| aSUVmax-A | −27% | 36% | −34% to −22% | 28% to 51% |
| aSUVmax-M | −28% | 38% | −34% to −23% | 30% to 52% |
| aSUVmax-P | −27% | 38% | −32% to −24% | 32% to 47% |
| aSUVpeak-A | −25% | 33% | −31% to −21% | 26% to 46% |
| aSUVpeak-M | −31% | 45% | −38% to −26% | 36% to 62% |
| aSUVpeak-P | −29% | 41% | −33% to −25% | 34% to 50% |
Results of ACRIN trial are denoted with -A, those from Merck trial with -M, and those from pooled ACRIN and Merck data with -P.